» Articles » PMID: 37228128

Induction of Pro-inflammatory Genes by Fibronectin DAMPs in Three Fibroblast Cell Lines: Role of TAK1 and MAP Kinases

Overview
Journal PLoS One
Date 2023 May 25
PMID 37228128
Authors
Affiliations
Soon will be listed here.
Abstract

Changes in the organization and structure of the fibronectin matrix are believed to contribute to dysregulated wound healing and subsequent tissue inflammation and tissue fibrosis. These changes include an increase in the EDA isoform of fibronectin as well as the mechanical unfolding of fibronectin type III domains. In previous studies using embryonic foreskin fibroblasts, we have shown that fibronectin's EDA domain (FnEDA) and the partially unfolded first Type III domain (FnIII-1c) function as Damage Associated Molecular Pattern (DAMP) molecules to stimulate the induction of inflammatory cytokines by serving as agonists for Toll-Like Receptor-4 (TLR4). However, the role of signaling molecules downstream of TLR-4 such as TGF-β Activated Kinase 1 (TAK1) and Mitogen activated protein kinases (MAPK) in regulating the expression of fibronectin DAMP induced inflammatory genes in specific cell types is not known. In the current study, we evaluate the molecular steps regulating the fibronectin driven induction of inflammatory genes in three human fibroblast cell lines: embryonic foreskin, adult dermal, and adult kidney. The fibronectin derived DAMPs each induce the phosphorylation and activation of TAK1 which results in the activation of two downstream signaling arms, IKK/NF-κB and MAPK. Using the specific inhibitor 5Z-(7)-Oxozeanol as well as siRNA, we show TAK1 to be a crucial signaling mediator in the release of cytokines in response to fibronectin DAMPs in all three cell types. Finally, we show that FnEDA and FnIII-1c induce several pro-inflammatory cytokines whose expression is dependent on both TAK1 and JNK MAPK and highlight cell-type specific differences in the gene-expression profiles of the fibroblast cell-lines.

Citing Articles

Critical Analysis of Cytoplasmic Progression of Inflammatory Signaling Suggests Potential Pharmacologic Targets for Wound Healing and Fibrotic Disorders.

Samulevich M, Carman L, Aneskievich B Biomedicines. 2025; 12(12.

PMID: 39767629 PMC: 11726985. DOI: 10.3390/biomedicines12122723.


Gall Ethanolic Extract Accelerates Wound Healing through Attenuating Inflammation and Oxidative Injuries in Skin Fibroblasts.

Wunnoo S, Sermwittayawong D, Praparatana R, Voravuthikunchai S, Jakkawanpitak C Antioxidants (Basel). 2024; 13(9).

PMID: 39334753 PMC: 11428264. DOI: 10.3390/antiox13091094.

References
1.
Crowley T, Buckley C, Clark A . Stroma: the forgotten cells of innate immune memory. Clin Exp Immunol. 2018; 193(1):24-36. PMC: 6038004. DOI: 10.1111/cei.13149. View

2.
Pulskens W, Teske G, Butter L, Roelofs J, van der Poll T, Florquin S . Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One. 2008; 3(10):e3596. PMC: 2570789. DOI: 10.1371/journal.pone.0003596. View

3.
Kelsh-Lasher R, Ambesi A, Bertram C, McKeown-Longo P . Integrin α4β1 and TLR4 Cooperate to Induce Fibrotic Gene Expression in Response to Fibronectin's EDA Domain. J Invest Dermatol. 2017; 137(12):2505-2512. PMC: 6736604. DOI: 10.1016/j.jid.2017.08.005. View

4.
Bhattacharyya S, Varga J . Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy. Immunol Lett. 2017; 195:9-17. PMC: 5820196. DOI: 10.1016/j.imlet.2017.09.011. View

5.
Bhattacharyya S, Tamaki Z, Wang W, Hinchcliff M, Hoover P, Getsios S . FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci Transl Med. 2014; 6(232):232ra50. PMC: 4414050. DOI: 10.1126/scitranslmed.3008264. View